<hr>
<h2>
    Session I – Hot Topics
</h2>
<span>Moderator: Lin Chang, MD, AGAF</span>
<hr>


<p>
    <u>8:15–8:20 a.m. </u>
    <br>
    <b>President’s Welcome </b>
    <br>
    <i>Sheila Crowe, MD, AGAF (UCSD)</i>
</p>

<p>
    <u>8:20–8:25 a.m. </u>
    <br>
    <b>Course Overview </b>
    <br>
    <i>Lin Chang, MD, AGAF (UCLA)</i>
</p>

<p>
    <u>8:25-8:43 a.m.</u>
    <br>
    <b>Managing HBV reactivation: Chemotherapy and immunosuppression </b>
    <br>
    <i>Raj Reddy (Penn)</i>
</p>

<p>
    <u>8:45-9:03 a.m. </u>
    <br>
    <b>Endoscopic Treatment Options for Obesity </b>
    <br>
    <i>Steve Edmundowicz (Colorado)</i>
</p>

<p>
    <u>9:05-9:23 a.m. </u>
    <br>
    <b>Uses of Fecal Microbial Transplantation in 2018 </b>
    <br>
    <i>Neil Stollman (UCSF)</i>
</p>

<p>
    <u>9:25-9:43 a.m </u>
    <br>
    <b>Top 3 Clinical Articles Published in Gastroenterology and CGH in the Past Year </b>
    <br>
    <i>Fasiha Kanwal (Baylor)</i>
</p>


<p>
    <u>9:45-10:05 a.m.</u>
    <br>
    <b>Refreshment Break</b>
</p>


<hr>
<h2>
    Session II – Inflammatory Bowel Disease (IBD)
</h2>
<span>Moderator: David Weinberg, MD, MSc, AGAF</span>
<hr>

<p>
    <u>10:05-10:23 a.m. </u>
    <br>
    <b>Deciding the first choice therapy for UC and Crohn's disease </b>
    <br>
    <i>Uma Mahadevan (UCSF)</i>
</p>

<p>
    <u>10:25-10:43 a.m. </u>
    <br>
    <b>Withdrawing biologics in IBD: Never or if Ever, Then How? </b>
    <br>
    <i>Millie Long (UNC)</i>
</p>

<p>
    <u>10:45-11:03a.m. </u>
    <br>
    <b>Use of Biosimilars in the Treatment of IBD </b>
    <br>
    <i>Peter Lakatos (McGill)</i>
</p>

<p>
    <u>11:05-11:23a.m. </u>
    <br>
    <b>Overlap of IBD and IBS </b>
    <br>
    <i>Charles Bernstein (Univ of Manitoba)</i>
</p>



<h2>Luncheon Breakout</h2>
<p>
    <u>11:45 a.m.-12:45 p.m.</u>
    <br>
    <b>Luncheon Breakout Sessions</b>
</p>


<p>
    <b>HCC Screening: Who, When and How?</b>
    <br> Laura Kulik (Northwestern Univ)
</p>

<p>
    <b>Management of Hepatorenal Syndrome, Now and in the Future</b>
    <br> Robert Brown (Columbia)
</p>


<p>
    <b>IgG4 Pancreatitis/Cholangitis: I found it, Now What? </b>
    <br> James Farrell (Yale)
</p>

<p>
    <b>Chronic Pancreatitis: Enzyme replacement and Nutritional Management </b>
    <br> Stephen McClave (U Louisville)
</p>

<p>
    <b>MELD Exceptions for Liver Transplantation: A New Landscape </b>
    <br> Scott Biggins, (U Washington)
</p>

<p>
    <b>Advances in Small Bowel Imaging </b>
    <br> Laurel Fisher (Penn)
</p>

<p>
    <b>Novel IBD Agents </b>
    <br> Uma Mahadevan (UCSF)
</p>

<p>
    <b>Precision Medicine in GI </b>
    <br> Gianrico Farrugia (Mayo)
</p>

<p>
    <b>Diagnosis of Food Allergy and Sensitivity </b>
    <br> Elena Verdu (McMaster)
</p>

<p>
    <b>Lumen Apposing Stents </b>
    <br> Jeff Tokar (Fox Chase)
</p>

<p>
    <b>Management of Abdominal Bloating and Distension </b>
    <br> Lucinda Harris (Mayo)
</p>

<p>
    <b>Evaluation and Treatment of Fecal Incontinence </b>
    <br> Anne Marie Boller (Northwestern)
</p>

<p>
    <b>Challenges in the Diagnosis and Treatment of Dysplastic Barrett's Esophagus </b>
    <br> Raman Muthusamy (UCLA)
</p>

<p>
    <b>Interpreting Esophageal Motility Tests and Applying Them to Patient Management </b>
    <br> Michael Vaezi (Vanderbilt Univ)
</p>

<p>
    <b>Maximizing the Patient-Provider Relationship using Effective Communication Skills for IBD and/or IBS </b>
    <br> Douglas Drossman (UNC) and Laurie Keefer (Mount Sinai)
</p>






<hr>
<h2>
    Session III – The Biliary Tree and Pancreas
</h2>
<span>Moderator: Carl Berg, MD, AGAF, FAASLD</span>
<hr>

<p>
    <u>
        12:45-1:03 p.m.
    </u>
    <br>
    <b>Prevention of Post-ERCP Pancreatitis Michelle Anderson (Univ Michigan)</b>
</p>

<p>
    <u>
        1:05-1:23 p.m.
    </u>
    <br>
    <b>Auto-Islet Cell Transplantation for Chronic Pancreatitis Tim Pruett (U Minn)</b>
</p>

<p>
    <u>
        1:25-1:43 p.m.
    </u>
    <br>
    <b>MDR Infection and ERCP Scopes: Best Practices and Future Directions Bret Petersen (Mayo)</b>
</p>

<p>
    <u>
        1:45-2:03 p.m.
    </u>
    <br>
    <b>Pancreatic Cystic Lesions: Watch, Wait or Intervene? Jim Scheiman (UVA)</b>
</p>


<hr>
<h2>
    Session IV – Liver
</h2>
<span>Moderator: Carl Berg, MD, AGAF, FAASLD</span>
<hr>

<p>
    <u>
        2:05-2:23 p.m.
    </u>
    <br>
    <b>Beta-blockers in cirrhosis: Friend or Foe? Guadelupe Garcia-Tsao (Yale)</b>
</p>

<p>
    <u>
        2:25-2:43 p.m.
    </u>
    <br>
    <b>Assessment of Fibrosis in NAFLD: Is Biopsy Ancient History? Rohit Loomba (UCSD)</b>
</p>

<p>
    <u>
        2:45-3:03 p.m.
    </u>
    <br>
    <b>Portal Vein Thrombosis in Cirrhosis: Anticoagulation- Yea or Nay? Patrick Northup (UVA)</b>
</p>

<p>
    <u>
        3:05-3:23 p.m.
    </u>
    <br>
    <b>Therapy of Chronic HBV: When to Start and When to End? Tran Tram (Cedars Sinai)</b>
</p>

<p>
    <u>
        3:25-3:43 p.m.
    </u>
    <br>
    <b>Practical Management of DAAs for Hepatitis C Andrew Muir (Duke)</b>

</p>

<p>
    <u>
        3:45-4 p.m.
    </u>
    <br>
    <b>Refreshment Break</b>
</p>




<hr>
<h2>
    Case-Based Session
</h2>
<hr>
<p>
    <u>4-5:30 p.m.</u>
    <br>
    <b>Case-Based Sessions</b>
</p>

<p>
    <b>Management of Autoimmune Hepatitis: When the Practice Guidelines Aren't </b>
    <br> Working Scott Biggins, (U Washington), Lindsay King (Duke)
</p>

<p>
    <b>Management of Acute Alcoholic Hepatitis in 2018 </b>
    <br> Michael Lucey (Univ Wisconsin), Jessica Mellinger (U Mich)
</p>

<p>
    <b>Treatment of NAFLD: Is There Anything Better than Weight Loss? </b>
    <br> Naga Chalasani (IU), Manal Abdelmalek (Duke)
</p>

<p>
    <b>Treatment of Infected Pancreatic Necrosis, Antibiotics, Drains, Hoses or the Knife? </b>
    <br> Andy Ross (Virginia Mason), Greg Cote (MUSC)
</p>

<p>
    <b>Endoscopic and Other Approaches to the Treatment of Chronic Pancreatitis </b>
    <br> Martin Freeman (U Minnesota), Stephen Kim (UCLA)
</p>

<p>
    <b>Short Gut Syndrome: What’s the Long and the Short of It? </b>
    <br> Alan Buchman (UIC), Chris Duggan (Boston Children’s)
</p>

<p>
    <b>FODMAPs and Beyond </b>
    <br> Peter Gibson (Monash Univ), Shanti Eswaren (Univ of Michigan)
</p>

<p>
    <b>Approaches to Celiac Disease and Non-Celiac Gluten Sensitivity </b>
    <br> Sheila Crowe (UCSD), Guy Weiss (UCLA)
</p>

<p>
    <b>Endoscopic Surveillance in IBD </b>
    <br> Charles Bernstein (Univ of Manitoba), Christina Ha (Cedars-Sinai)
</p>

<p>
    <b>Postoperative Management of IBD: IPAA and Ileocolectomy </b>
    <br> Milli Long (UNC), Jenny Sauk (UCLA)
</p>

<p>
    <b>Different Therapeutic Options for Achalasia: Who Should Get What? </b>
    <br> Michael Vaezi (Vandebilt), Walter Chan (Brigham and Women’s)
</p>

<p>
    <b>Breath testing: Role in Diagnosis and Prediction of Treatment Response </b>
    <br> William D. Chey (Univ of Michigan), David Kunkel (UCSD)
</p>

<p>
    <b>Clinical Pearls in Managing IBS and Chronic Abdominal Pain </b>
    <br> Douglas Drossman (UNC), Joanne Wilson (Duke)
</p>

<p>
    <b>Segmental Colitis Associated Diverticulosis (SCAD) </b>
    <br> Neill Stollman (UCSF), Joseph Feuerstein (Beth Israel)
</p>

<p>
    <b>NERD, Functional Heartburn and Reflux Hypersensitivity All Cause Heartburn – How to Separate Them in Clinical Practice
    </b>
    <br> Ronnie Fass (Case Western Reserve Univ), Gregory Sayuk (Washington Univ)
</p>